Targeting the proangiogenic VEGF-VEGFR protein-protein interface with drug-like compounds by in silico and in vitro screening.
Gautier B, Miteva MA, Goncalves V, Huguenot F, Coric P, Bouaziz S, Seijo B, Gaucher JF, Broutin I, Garbay C, Lesnard A, Rault S, Inguimbert N, Villoutreix BO, Vidal M.
Gautier B, et al.
Chem Biol. 2011 Dec 23;18(12):1631-9. doi: 10.1016/j.chembiol.2011.10.016.
Chem Biol. 2011.
PMID: 22195565